Added Duodenoscope Reprocessing Steps Will Reduce Risks, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
FDA recommended four additional duodenoscope reprocessing measures hospitals and infection control practitioners can take to reduce infection risks to patients, including microbiological culturing, ethylene oxide sterilization, liquid chemical sterilant reprocessing and repeat high-level disinfection.
You may also be interested in...
Duodenoscope-Makers Ordered By FDA To Conduct Sec. 522 Postmarket Surveillance Studies
FDA orders three duodenoscope manufacturers – Olympus America, Fujifilm Medical Systems and Hoya Corp.'s Pentax Life Care Division – to conduct postmarket surveillance studies to better understand how the scopes are being reprocessed and how to reduce the risk of patient infection. The firms told "The Gray Sheet" that they will comply with the agency's request.
FDA Advisors Call For New Cleaning Methods, Sterilization For Duodenoscopes
Current reprocessing methods for duodenoscopes provide no reasonable assurance of safety and effectiveness, and manual cleaning steps need improvement, an FDA panel said. Most panelists called for upgrading manual cleaning, followed by lengthy sterilization of the products until they can be redesigned.
FDA Lays Down Strict Disinfection Guidance In Wake Of Scope Incidents
The agency sped up release of a final guidance on reprocessing reusable devices, including a strict set of protocols for endoscope cleaning, disinfection data, and design guidelines, following reports of serious bacterial infections linked to duodenoscopes.